|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| August 2011 Volume 11 Number 8 | Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| In this issue
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| From the editors p533 | doi:10.1038/nrc3118 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advances in sarcoma genomics and new therapeutic targets Barry S. Taylor, Jordi Barretina, Robert G. Maki, Cristina R. Antonescu, Samuel Singer & Marc Ladanyi p541 | doi:10.1038/nrc3087 Sarcomas are increasingly classified according to the genetic abnormalities associated with their pathogenesis. What are the mechanisms of sarcomagenesis and how might these genetic abnormalities lead to improved therapy for patients? Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cyclin D as a therapeutic target in cancer Elizabeth A. Musgrove, C. Elizabeth Caldon, Jane Barraclough, Andrew Stone & Robert L. Sutherland p558 | doi:10.1038/nrc3090 Is the ability of D-type cyclins to activate cyclin-dependent kinases an effective means of targeting these oncogenes, and how might the patient subgroups that are most likely to benefit be identified? Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chemotaxis in cancer Evanthia T. Roussos, John S. Condeelis & Antonia Patsialou p573 | doi:10.1038/nrc3078 Chemotaxis confers directionality to migrating tumour cells away from the tumour and recruits various cells to the tumour. This Review discusses the mechanisms of chemotaxis and how this process contributes to tumour progression. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cancer biology and NuRD: a multifaceted chromatin remodelling complex Anne Y. Lai & Paul A. Wade p588 | doi:10.1038/nrc3091 The nucleosome remodelling and histone deacetylase (NuRD) complex has been implicated in the regulation of transcriptional events that are integral to oncogenesis and cancer progression. This Review discusses how inappropriate localization of the complex could contribute to tumour biology. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The different roles of ER subtypes in cancer biology and therapy Christoforos Thomas & Jan-Åke Gustafsson p597 | doi:10.1038/nrc3093 Perturbation of oestrogen receptor (ER) subtype-specific expression has been detected in various types of cancer, and these differences correlate with the clinical outcome. The selective restoration or ablation of their activity is one of the major therapeutic approaches for hormone-dependent cancers. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Calcium in tumour metastasis: new roles for known actors Natalia Prevarskaya, Roman Skryma & Yaroslav Shuba p609 | doi:10.1038/nrc3105 The ubiquitous second messenger Ca2+ is a crucial regulator of cell migration. This Review discusses recent data on ORAI1, STIM1 and TRP, which have been implicated in tumour cell migration and the metastatic cell phenotype. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CORRESPONDENCE | Top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Correspondence: The two faces of autophagy and the pathological underestimation of DCIS Ke-Da Yu & Zhi-Ming Shao p618 | doi:10.1038/nrc2950-c1 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Correspondence: A response to the two faces of autophagy in DCIS Virginia Espina & Lance A. Liotta p618 | doi:10.1038/nrc2950-c2 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Erratum: Otto Warburg's contributions to current concepts of cancer metabolism Willem H. Koppenol, Patricia L. Bounds & Chi V. Dang p618 | doi:10.1038/nrc3108 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| *2010 Journal Citation Report (Thomson Reuters, 2011) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
![]() |




Roche / Nature Medicine Symposium on Cancer Immunology and Immunotherapy 



No comments:
Post a Comment